DE69836591D1 - Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen - Google Patents
Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungenInfo
- Publication number
- DE69836591D1 DE69836591D1 DE69836591T DE69836591T DE69836591D1 DE 69836591 D1 DE69836591 D1 DE 69836591D1 DE 69836591 T DE69836591 T DE 69836591T DE 69836591 T DE69836591 T DE 69836591T DE 69836591 D1 DE69836591 D1 DE 69836591D1
- Authority
- DE
- Germany
- Prior art keywords
- hasic3
- proton
- neurons
- sensory
- gated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2219713 | 1997-10-29 | ||
CA2219713 | 1997-10-29 | ||
PCT/CA1998/001016 WO1999021981A1 (en) | 1997-10-29 | 1998-10-29 | Dna encoding a human proton-gated ion channel and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69836591D1 true DE69836591D1 (de) | 2007-01-18 |
DE69836591T2 DE69836591T2 (de) | 2007-09-20 |
Family
ID=4161708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69836591T Expired - Lifetime DE69836591T2 (de) | 1997-10-29 | 1998-10-29 | Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1025226B1 (de) |
AT (1) | ATE347596T1 (de) |
AU (1) | AU9732498A (de) |
CA (1) | CA2308014A1 (de) |
DE (1) | DE69836591T2 (de) |
ES (1) | ES2279583T3 (de) |
WO (1) | WO1999021981A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287859B1 (en) * | 1998-08-05 | 2001-09-11 | Centre National De La Recherche | Identification, functional expression and chromosal localization of a sustained human proton-gated cation channel |
ATE420636T1 (de) | 1999-05-19 | 2009-01-15 | Painceptor Pharma Corp | Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen |
US6548270B1 (en) | 2000-03-03 | 2003-04-15 | Ortho-Mcneil Pharmaceutical, Inc. | DNA encoding human acid-sensing ion channel BNaC4 (ASIC4) |
CA2304494A1 (en) | 2000-04-20 | 2001-10-20 | Philippe Seguela | A novel heteromultimeric ion channel receptor and uses thereof |
US9371383B2 (en) | 2012-01-31 | 2016-06-21 | Regeneron Pharmaceuticals, Inc. | Anti-ASIC1 antibodies and uses thereof |
ES2707599T3 (es) | 2012-01-31 | 2019-04-04 | Regeneron Pharma | Anticuerpos anti-asic1 y usos de los mismos |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513180D0 (en) * | 1995-06-28 | 1995-08-30 | Univ London | Ion channel |
FR2759373B1 (fr) * | 1997-02-11 | 2001-05-04 | Centre Nat Rech Scient | Nouveau canal cationique neuronal de mammifere sensible a l'acidite, son clonage et ses applications |
EP0884386A1 (de) * | 1997-05-30 | 1998-12-16 | Synthelabo | Natrium-Ionenkanäle Rezeptor |
-
1998
- 1998-10-29 EP EP98951141A patent/EP1025226B1/de not_active Expired - Lifetime
- 1998-10-29 DE DE69836591T patent/DE69836591T2/de not_active Expired - Lifetime
- 1998-10-29 AT AT98951141T patent/ATE347596T1/de not_active IP Right Cessation
- 1998-10-29 WO PCT/CA1998/001016 patent/WO1999021981A1/en active IP Right Grant
- 1998-10-29 CA CA002308014A patent/CA2308014A1/en not_active Abandoned
- 1998-10-29 ES ES98951141T patent/ES2279583T3/es not_active Expired - Lifetime
- 1998-10-29 AU AU97324/98A patent/AU9732498A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1025226B1 (de) | 2006-12-06 |
DE69836591T2 (de) | 2007-09-20 |
ATE347596T1 (de) | 2006-12-15 |
CA2308014A1 (en) | 1999-05-06 |
WO1999021981A1 (en) | 1999-05-06 |
AU9732498A (en) | 1999-05-17 |
EP1025226A1 (de) | 2000-08-09 |
ES2279583T3 (es) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dolphin et al. | Presynaptic calcium channels: specialized control of synaptic neurotransmitter release | |
Rajakulendran et al. | Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS | |
Cassano et al. | Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease | |
Ahmad et al. | Genomic organization of the human hairless gene (HR) and identification of a mutation underlying congenital atrichia in an Arab Palestinian family | |
Albrecht et al. | The ABCA subfamily—gene and protein structures, functions and associated hereditary diseases | |
Klugbauer et al. | Calcium channel α 2 δ subunits: Differential expression, function, and drug binding | |
Shafer et al. | The D3 dopamine receptor in cellular and organismal function | |
Klammt et al. | IGF1R mutations as cause of SGA | |
Gobeil et al. | Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants | |
Specht et al. | Effects of presynaptic mutations on a postsynaptic Cacna1s calcium channel colocalized with mGluR6 at mouse photoreceptor ribbon synapses | |
Bhat et al. | Functional and biochemical consequences of disease variants in neurotransmitter transporters: a special emphasis on folding and trafficking deficits | |
Zoidl et al. | Gap junctions in inherited human disease | |
Schaefer et al. | Molecular cloning, functional expression and chromosomal localization of an amiloride-sensitive Na+ channel from human small intestine | |
Dhingra et al. | mGlu receptors in the retina | |
Chen et al. | Functional analysis of nonsynonymous single nucleotide polymorphisms in human SLC26A9 | |
Solé et al. | Trafficking mechanisms underlying Nav channel subcellular localization in neurons | |
Chandran et al. | Alsin and the molecular pathways of amyotrophic lateral sclerosis | |
DE69836591D1 (de) | Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen | |
Zafra et al. | Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies | |
Liu et al. | A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome | |
Han et al. | Tadr is an axonal histidine transporter required for visual neurotransmission in Drosophila | |
US6287859B1 (en) | Identification, functional expression and chromosal localization of a sustained human proton-gated cation channel | |
Barhanin et al. | IKs, a slow and intriguing cardiac K+ channel and its associated long QT diseases | |
Takamiya et al. | Overexpression of mutated Cu, Zn-SOD in neuroblastoma cells results in cytoskeletal change | |
Mckeown et al. | Molecular basis of inherited calcium channelopathies: role of mutations in pore‐forming subunits 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, 805 |